CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

CHEMED CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026

$508.29−4.09 (-0.80%)

Close on Oct 19, 2026

Market cap: $6.71B
P/E (TTM): 25.5
Dividend yield: 0.43%

Fundamental chart

Pick a measure to chart its full history

$2.53BFY2025, +4.6% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Chemed's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on May 12, 2005
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CHE.

Revenue growth3.3% · median 15.9%

Gross margin33.1% · median 19.1%

Operating margin13.5% · median 5.9%

Net margin10.6% · median 3.7%

Company	Revenue	Growth
BTSG	$14.37B	+26.4%
OPCH	$5.69B	+5.9%
AHCO	$3.23B	+4.2%
AVAH	$2.60B	+19.5%
CHE	$2.60B	+3.3%
ADUS	$1.48B	+15.9%

Company

Next earnings (est.): Oct 27, 2026, after close
Exchange: NYSE
Industry: Services-Home Health Care Services
Fiscal year ends: December 31
Employees: 15,811
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 19584

Advertisement
300 × 250